2018 Programme

The 2018 NCRI Conference will be held from Sunday 4 November – Tuesday 6 November 2018.

Register now

Download the PDF version of the programme

Use the filters below to browse and view the full 2018 NCRI Cancer Conference programme across multiple streams and all three days.

Filter and search

Reset filters
Choose a stream [+]
Choose a session type [+]
Choose a session date [+]

Programme Details

Sunday 4 November
Sunday, 4 Nov 2018
09:00-19:00
External
2018 BASO – ACS Annual Scientific Conference
Sunday, 4 Nov 2018
13:00-13:15
Armadillo - Clyde Auditorium (G)
Opening speech
Sunday, 4 Nov 2018
13:15-13:55
Armadillo - Clyde Auditorium (G)
Precision oncology
Speaker: Charles Swanton, The Francis Crick Institute, UK
Sunday, 4 Nov 2018
13:55-14:35
Armadillo - Clyde Auditorium (G)
Applying genetic information to prevent colorectal cancer
Speaker: Malcolm Dunlop, University of Edinburgh, UK
Sunday, 4 Nov 2018
14:35-15:15
Armadillo - Clyde Auditorium (G)
Molecular Imaging of Immunotherapies
Speaker: Sam Gambhir, Stanford University School of Medicine, USA
Sunday, 4 Nov 2018
15:00-00:00
Exhibition - Hall 4
Exhibition opens
Sunday, 4 Nov 2018
15:15-15:45
Exhibition - Hall 4
Coffee break, networking, exhibition and poster viewing
Sunday, 4 Nov 2018
15:20-15:40
Exhibition - Hall 4
Silent Theatres
Sunday, 4 Nov 2018
15:45-15:50
Armadillo - Clyde Auditorium (G)
Welcome speech from Lord Provost
Sunday, 4 Nov 2018
15:50-16:30
Armadillo - Clyde Auditorium (G)
Brain tumours – preclinical to clinical
Speaker: Richard Gilbertson, CRUK Cambridge Institute, UK
Sunday, 4 Nov 2018
16:35-18:35
Hall 1
Tumour immunology and metabolic immunotherapy
Chair: Susan Critchlow, Astrazeneca, UK
Speaker: Martin Miller, CRUK Cambridge Institute, UK
Speaker: Vincenzo Bronte, Federazione Ricerca Biomedica Avanzata Onlus, Italy
Speaker: Saverio Tardito, CRUK Beatson Institute, UK
Sunday, 4 Nov 2018
16:35-18:35
Dochart
Melanoma
Chair: Elizabeth Patton, CRUK Edinburgh Centre
Speaker: David Adams, Wellcome Trust Sanger Institute, UK
Speaker: Richard Marais, CRUK Manchester Institute, UK
Speaker: Richard White, Memorial Sloan Kettering Cancer Centre, USA
Sunday, 4 Nov 2018
16:35-18:35
Carron
Data driven technologies
Chair: David Weller, University of Edinburgh, UK
Speaker: Andrew Morris, Health Data Research UK
Speaker: Alan Karthikesalingam, Deep Mind Health
Speaker: Eva Morris, University of Leeds, UK
Sunday, 4 Nov 2018
16:35-18:35
Seminar Suite
What does multi-morbidity mean for cancer treatment and outcomes
Chair: Peter Murchie, University of Aberdeen, UK
Speaker: Alison Fielding, NCRI Consumer Forum, UK
Speaker: David Blane, University of Glasgow, UK
Speaker: Katriina Whitaker, University of Surrey, UK
Sunday, 4 Nov 2018
16:35-18:35
M1
Cancer research strategy and implementation
Speaker: Tom Crosby, Wales Cancer Network, UK
Speaker: Miriam McCarthy, Health and Social Care Board Northern Ireland, UK
Speaker: David Dunlop, Scottish Government Chief Scientist Office, UK
Speaker: David Fitzgerald, NHS England, UK
Sunday, 4 Nov 2018
16:35-18:35
Boisdale
Modelling the biology of glioblastoma
Chair: Simona Parrinello, University College London, UK
Speaker: Anthony Chalmers, University of Glasgow, UK
Speaker: Steve Pollard, University of Edinburgh, UK
Speaker: Peter Dirks, Sick Kids, Canada
Sunday, 4 Nov 2018
18:40-19:25
Hall 1
Why is cancer so difficult? Understanding and measuring variability
Speaker: Martin Christlieb, University of Oxford, UK
Sunday, 4 Nov 2018
18:40-19:25
Lomond Auditorium
Breast Cancer Now presents ‘Science Simplified’
Sunday, 4 Nov 2018
18:40-19:25
Alsh
NCRI Trainee network event
Sunday, 4 Nov 2018
19:30-21:00
Exhibition - Hall 4
Opening reception, networking, poster and exhibition viewing
Sunday, 4 Nov 2018
19:40-21:00
Exhibition - Hall 4
Silent Theatres
Sunday, 4 Nov 2018
19:45-20:55
Exhibition - Hall 4
Igloo

Monday 5 November
Monday, 5 Nov 2018
08:15-09:00
Carron
Impact on treatment decision depending on method for Liquid Biopsy testing. Comparative study – Agena Bioscience sponsored session
Speaker: Pierre-Jean Lamy, Institut Médical d’Analyse Génomique, Montpellier, France
Monday, 5 Nov 2018
08:15-09:00
Alsh
Demystifying today’s science
Speaker: Elaine Vickers, Science Communicated Ltd, UK
Monday, 5 Nov 2018
08:15-08:45
Exhibition - Hall 4
Relaxation session
Monday, 5 Nov 2018
08:15-09:00
Dochart
Dissecting the tumor microenvironment – tools for cell isolation and flow analysis – Miltenyi Biotec sponsored session
Speaker: Carsten Studte, Global Product Manager, Miltenyi Biotec, UK
Monday, 5 Nov 2018
08:15-09:00
Boisdale
Proffered papers session
Monday, 5 Nov 2018
09:05-09:45
Armadillo - Clyde Auditorium (G)
Why is behavioural change so difficult?
Speaker: Theresa Marteau, University of Cambridge, UK
Monday, 5 Nov 2018
09:45-10:25
Armadillo - Clyde Auditorium (G)
Alcohol, endogenous aldehydes and DNA damage in stem cells
Speaker: KJ Patel, MRC Laboratory of Molecular Biology, UK
Monday, 5 Nov 2018
10:25-11:00
Exhibition - Hall 4
Networking, poster and exhibition viewing
Monday, 5 Nov 2018
10:30-10:55
Exhibition - Hall 4
Igloo
Monday, 5 Nov 2018
10:30-10:55
Exhibition - Hall 4
Silent Theatres
Monday, 5 Nov 2018
11:00-12:30
Hall 1
Recent advances in cancer immunology and immunotherapy
Chair: Sergio Quezada, University College London, UK
Speaker: Nicholas McGranahan, Francis Crick Institute, UK
Speaker: Burkhard Becher, University of Zurich, Switzerland
Speaker: Sine Reker Hadrup, Technical University of Denmark, Denmark
Monday, 5 Nov 2018
11:00-12:30
Alsh
A personalised approach to treating patients with haematological malignancies
Chair: Mhairi Copland, University of Glasgow, UK
Speaker: Anna Schuh, University of Oxford, UK
Speaker: Susanne Saussele, University of Mannheim, Germany
Speaker: Paresh Vyas, University of Oxford, UK
Monday, 5 Nov 2018
11:00-12:30
Boisdale
Liquid biopsies in monitoring treatment
Chair: Nicholas Turner, The Institute of Cancer Research, UK
Speaker: Nitzan Rosenfeld, CRUK Cambridge Institute, UK
Speaker: Johann de Bono, The Institute of Cancer Research, UK
Speaker: Thomas Wurdinger, Neurosurgical Center Amsterdam, The Netherlands
Monday, 5 Nov 2018
11:00-12:30
Seminar Suite
Environmental exposure and cancer prevention
Chair: Linda Bauld, University of Stirling, UK
Speaker: Marion MacFarlane, University of Leicester, UK
Speaker: Lion Shahab, University College London, UK
Speaker: John Cherrie, Heriot Watt University, Edinburgh, UK
Monday, 5 Nov 2018
11:00-12:30
Carron
Proffered papers session (Prize winners)
Monday, 5 Nov 2018
11:00-12:30
Dochart
Genomics in the clinic: Context, care and communication
Chair: Sarah Cunningham-Burley, University of Edinburgh, UK
Speaker: Rikke Sand Anderson, Aarhus University, Denmark
Speaker: Sophie Day, Goldsmiths, University of London, UK
Speaker: Anne Kerr, University of Leeds, UK
Monday, 5 Nov 2018
12:30-14:00
Exhibition - Hall 4
Lunch, networking, exhibition and poster viewing
Monday, 5 Nov 2018
12:40-13:55
Exhibition - Hall 4
Silent Theatres
Monday, 5 Nov 2018
13:00-14:00
Alsh
From research to reality: molecular biomarkers in immuno-oncology – Bristol-Myers Squibb sponsored session
Chair: Gary Middleton, University of Birmingham, UK
Speaker: Mike Hubank, The Royal Marsden, UK
Speaker: John Gosney, Royal Liverpool University Hospital, UK
Monday, 5 Nov 2018
13:00-14:00
M1
Dragons’ den
Monday, 5 Nov 2018
13:00-14:00
Carron
BASO Prizes and Awards session
Monday, 5 Nov 2018
14:00-16:00
Dochart
Myeloid innate immunity
Chair: Jeffrey Pollard, University of Edinburgh, UK
Speaker: Michael Schmid, University of Liverpool, UK
Speaker: Fran Balkwill, Barts Cancer Institute, UK
Speaker: Miki De Palma, Swiss Institute for Experimental Cancer Research, Switzerland
Monday, 5 Nov 2018
14:00-16:00
Boisdale
Cancer vulnerabilities
Chair: Chris Lord, The Institute of Cancer Research, UK
Speaker: Carla Martins, University of Cambridge, UK
Speaker: Jason Moffatt, University of Toronto, Canada
Speaker: Colm Ryan, University College Dublin, Ireland
Monday, 5 Nov 2018
14:00-16:00
Alsh
New approaches to cancer diagnostics, from bench to primary care
Chair: Fiona Walter, University of Cambridge, UK
Speaker: Richard Neal, University of Leeds, UK
Speaker: Steve Pereira, University College London, UK
Speaker: Jon Emery, University of Melbourne, Australia
Monday, 5 Nov 2018
14:00-16:00
Seminar Suite
The role of the surgeon in contemporary cancer research
Chair: Terry Jones, University of Liverpool, UK
Speaker: Alex Mirnezami, University of Southampton, UK
Speaker: Richard Shaw, University of Liverpool, UK
Speaker: Christobel Saunders, University of Western Australia, Australia
Monday, 5 Nov 2018
14:00-16:00
Hall 1
Clinical impact of immunotherapy
Chair: Poulam Patel, University of Nottingham, UK
Speaker: James Larkin, Royal Marsden NHS Foundation Trust, UK
Speaker: Paul Nathan, Mount Vernon Hospital, UK
Speaker: Mary O'Brien, Royal Marsden Hospital, UK
Monday, 5 Nov 2018
14:00-16:00
Lomond Auditorium
The reality of cancer treatment consequences
Chair: David Waller, Alive with Cancer, UK
Chair: Diana Greenfield, Sheffield Teaching Hospitals NHS Foundation Trust, UK
Speaker: Nick Robinson, BBC, Patient representative
Speaker: Adrian Edwards, University of Cardiff, UK
Speaker: Navneet Majhail, Cleveland Clinic, USA
Monday, 5 Nov 2018
14:00-16:00
Carron
Triple negative breast cancer
Chair: Adrian Harris, University of Oxford, UK
Speaker: Jean Abraham, University of Cambridge, UK
Speaker: Roger Daly, Monash University, Australia
Speaker: Peter Schmid, Barts Cancer Institute, UK
Monday, 5 Nov 2018
16:00-16:30
Exhibition - Hall 4
Networking, exhibition and poster viewing
Monday, 5 Nov 2018
16:05-16:30
Exhibition - Hall 4
Igloo
Monday, 5 Nov 2018
16:05-16:30
Exhibition - Hall 4
Silent Theatres
Monday, 5 Nov 2018
16:30-17:45
Lomond Auditorium
Best of translational science: Pancreatic cancer research
Chair: David Chang, University of Glasgow, UK
Speaker: George Miller, New York Langone Medical Center, USA
Speaker: Claus Jorgensen, CRUK, Manchester Institute, UK
Speaker: Jen Morton, CRUK, Beatson Institute, UK
Monday, 5 Nov 2018
16:30-17:45
M1
Clinical Trials Showcase
Monday, 5 Nov 2018
17:50-18:30
Armadillo - Clyde Auditorium (G)
CRUK Prizes session and Lifetime Achievement
Monday, 5 Nov 2018
19:30-23:59
Crowne Plaza Hotel
Conference social event

Tuesday 6 November
Tuesday, 6 Nov 2018
08:15-09:00
Alsh
Demystifying today’s science
Speaker: Elaine Vickers, Science Communicated Ltd, UK
Tuesday, 6 Nov 2018
08:15-09:00
Lomond Auditorium
A career in cancer research: What industry has to offer
Chair: Sue Bailey, Bristol-Myers Squibb, UK
Tuesday, 6 Nov 2018
08:15-08:45
Exhibition - Hall 4
Relaxation session
Tuesday, 6 Nov 2018
08:15-09:00
Carron
Why 3D imaging in preclinical trials is a step forward for cancer research – Fuel3D Sponsored session
Tuesday, 6 Nov 2018
08:15-09:00
Dochart
Proffered papers session
Tuesday, 6 Nov 2018
09:00-15:30
Seminar Suite
Schools event
Tuesday, 6 Nov 2018
09:05-09:45
Armadillo - Clyde Auditorium (G)
Cell function and tumour formation
Speaker: Stefano Piccolo, University of Padua, Italy
Tuesday, 6 Nov 2018
09:45-10:25
Armadillo - Clyde Auditorium (G)
Microbiome and mucosal immunology
Speaker: Fiona Powrie, Kennedy Institute of Rheumatology, UK
Tuesday, 6 Nov 2018
10:25-11:00
Exhibition - Hall 4
Networking, exhibition and poster viewing
Tuesday, 6 Nov 2018
10:30-10:55
Exhibition - Hall 4
Igloo
Tuesday, 6 Nov 2018
10:30-10:55
Exhibition - Hall 4
Silent Theatres
Tuesday, 6 Nov 2018
11:00-12:30
Hall 1
Cancer heterogeneity
Chair: Mariam Jamal-Hanjani, University College London Cancer Institute, UK
Speaker: Peter Van Loo, The Francis Crick Institute, UK
Speaker: Samra Turajlic, The Francis Crick Institute, UK
Speaker: Trevor Graham, Barts Cancer Institute, UK
Tuesday, 6 Nov 2018
11:00-12:30
M1
New cancer therapies
Chair: Caroline Springer, CRUK Manchester Institute, UK
Speaker: Ian Collins, The Institute of Cancer Research, UK
Speaker: John Bell, University of Ottawa, Canada
Speaker: Allan Jordan, CRUK Manchester Institute, UK
Tuesday, 6 Nov 2018
11:00-12:30
Carron
Population cancer screening: are we getting it right?
Chair: Ian Tomlinson, University of Birmingham, UK
Speaker: Linda Sharp, Newcastle University, UK
Speaker: Mette Kalager, University of Oslo, Norway
Speaker: Richard Martin, University of Bristol, UK
Tuesday, 6 Nov 2018
11:00-12:30
Boisdale
The promise of precision
Chair: Tim Maughan, University of Oxford, UK
Speaker: Peter O'Dwyer, University of Pennsylvania, USA
Speaker: Cindy Billingham, University of Birmingham, UK
Speaker: Rodrigo Dienstmann, Vall d'Hebron Institut d’Oncologia, Barcelona, Spain
Tuesday, 6 Nov 2018
11:00-12:30
Alsh
Spotlight on NCRI activities: Living with and beyond cancer initiative
Chair: Richard Stephens, NCRI Consumer Forum, UK
Speaker: Andrew Bottomley, European Organisation for Research and Treatment of Cancer (EORTC), Belgium
Speaker: Sam Ahmedzai, University of Sheffield, UK
Speaker: Ceinwen Giles, Shine Cancer Support, UK
Speaker: Galina Velikova, University of Leeds, UK
Tuesday, 6 Nov 2018
11:00-12:30
Dochart
Digital pathology
Chair: Karin Oien, University of Glasgow, UK
Speaker: Manuel Salto-Tellez, Queen's University Belfast, UK
Speaker: Nasir Rajpoot, University of Warwick, UK
Speaker: Yinyin Yuan, The Institute of Cancer Research, UK
Tuesday, 6 Nov 2018
12:30-14:00
Exhibition - Hall 4
Lunch, networking, exhibition and poster viewing
Tuesday, 6 Nov 2018
12:40-13:55
Exhibition - Hall 4
Silent Theatres
Tuesday, 6 Nov 2018
13:00-14:00
Boisdale
Proffered papers session
Tuesday, 6 Nov 2018
13:00-14:00
Lomond Auditorium
Meet the expert
Chair: Owen Sansom, CRUK, Beatson Institute, UK
Speaker: Gemma Pearce, Coventry University, UK
Speaker: Linda Bauld, University of Stirling, UK
Speaker: Pippa Corrie, Cambridge University Hospitals, UK
Speaker: Maria Hawkins, CRUK MRC Oxford Institute for Radiation Oncology, UK
Speaker: Terry Jones, University of Liverpool, UK
Speaker: Chris Lord, The Insitute of Cancer Research, UK
Speaker: Elizabeth Patton, CRUK Edinburgh Centre, UK
Tuesday, 6 Nov 2018
13:00-14:00
Alsh
Advances in pancreatic and biliary tract cancers: investigators’ perspectives – NuCana sponsored workshop
Speaker: Mairéad McNamara, Christie Hospital, Manchester, UK
Speaker: Juan W. Valle, Christie Hospital Manchester, UK
Speaker: Dan Palmer, University of Liverpool & Clatterbridge Cancer Centre
Tuesday, 6 Nov 2018
14:00-16:00
Boisdale
Understanding the role of TGFbeta signaling in cancer
Chair: Gareth Inman, University of Dundee, UK
Speaker: Joan Seoane, Val D’Hebron Institute of Oncology, Spain
Speaker: Caroline Hill, The Francis Crick Institute, UK
Speaker: Carl-Henrik Heldin, The Ludwig Institute for Cancer Research, UK
Tuesday, 6 Nov 2018
14:00-16:00
M1
Impact of a patient’s gut microbiome on clinical response to cancer immunotherapy
Chair: Trevor Lawley, Wellcome Trust Sanger Institute
Speaker: Robert Jenq, MD Anderson Cancer Center, USA
Speaker: Trevor Lawley, Wellcome Trust Sanger Institute, UK
Speaker: Paul O'Toole, University College Cork, Ireland
Tuesday, 6 Nov 2018
14:00-16:00
Hall 1
The burden of cancer due to inequalities and its likely causes
Chair: Yoryos Lyratzopoulos, University College London, UK
Speaker: Jo Waller, University College London, UK
Speaker: Nancy Keating, Harvard Medical School and Dana Farber. USA
Speaker: Bernard Rachet, London School of Hygiene and Tropical Medicine, UK
Tuesday, 6 Nov 2018
14:00-16:00
Alsh
Radiotherapy combinations
Chair: Maria Hawkins, CRUK MRC Oxford Institute for Radiation Oncology, UK
Speaker: Kaye Williams, The University of Manchester, UK
Speaker: Susan Short, University of Leeds, UK
Speaker: Alan Melcher, The Institute of Cancer Research, UK
Tuesday, 6 Nov 2018
14:00-16:00
Lomond Auditorium
The challenge of rare cancers
Chair: Richard Adams, University of Cardiff, UK
Speaker: Sheela Rao, Royal Marsden Hospital, UK
Speaker: Matt Sydes, University College London, UK
Speaker: Steve Nicholson, International Rare Cancers Initiative in Penile Cancer, UK
Tuesday, 6 Nov 2018
14:00-16:00
Dochart
Measuring what matters to healthcare professionals, patients and service providers
Chair: Lesley Fallowfield, University of Sussex, UK
Speaker: Derek Kyte, University of Birmingham, UK
Speaker: David Cella, CORE Core Outcomes Research Centre, Chicago, USA
Speaker: Jane Blazeby, University of Bristol, UK
Tuesday, 6 Nov 2018
14:00-16:00
Carron
Ovarian cancer – novel models and novel targets
Chair: Iain McNeish, Imperial College London, UK
Speaker: Ahmed Ahmed, University of Oxford, UK
Speaker: Stephen Taylor, University of Manchester, UK
Speaker: Charlie Gourley, University of Edinburgh, UK
Tuesday, 6 Nov 2018
16:00-16:30
Exhibition - Hall 4
Networking, exhibition and poster viewing
Tuesday, 6 Nov 2018
16:05-16:30
Exhibition - Hall 4
Igloo
Tuesday, 6 Nov 2018
16:05-16:30
Exhibition - Hall 4
Silent Theatres
Tuesday, 6 Nov 2018
16:30-17:10
Armadillo - Clyde Auditorium (G)
Head and neck cancer treatments
Speaker: Quynh-Thu Le, Stanford University, USA
Tuesday, 6 Nov 2018
17:10-17:30
Armadillo - Clyde Auditorium (G)
Closing remarks